GGS
TMO icon

Galvin Gaustad & Stein’s Thermo Fisher Scientific TMO Stock Holding History

Galvin Gaustad & Stein’s Portfolio TMO Stock Details TMO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q1 		– Sell
-1,221
Closed -$673K – 172
2022
Q4 		$673K Hold
1,221
– – 0.07% 104
2022
Q3 		$619K Sell
1,221
-63
-5% -$35.3K 0.07% 104
2022
Q2 		$698K Buy
+1,284
New +$707K 0.07% 102

Other funds holding TMO

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Massachusetts Financial Services
Massachusetts Financial Services Boston, Massachusetts $315B AUM 27.84% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return

Galvin Gaustad & Stein's TMO Position: Q1 2023 in Review

Galvin Gaustad & Stein sold out of Thermo Fisher Scientific (TMO) in Q1 2023, closing a stake of 1,221 shares — an estimated $673K sold.

Galvin Gaustad & Stein first reported a position in TMO in Q2 2022 and held it in 3 quarters. The position peaked at $698K in Q2 2022. 2,386 funds tracked by Wall St. Rank hold TMO as of Q1 2023.

  • Galvin Gaustad & Stein reported no remaining Thermo Fisher Scientific position as of Q1 2023 after selling out during the quarter.
  • Galvin Gaustad & Stein sold 1,221 Thermo Fisher Scientific shares in Q1 2023, an estimated $673K.
  • Galvin Gaustad & Stein first reported a position in Thermo Fisher Scientific in Q2 2022 and held it in 3 quarters.
  • Galvin Gaustad & Stein's Thermo Fisher Scientific position peaked at $698K in Q2 2022.
  • 2,386 funds tracked by Wall St. Rank held Thermo Fisher Scientific as of Q1 2023.

Based on Galvin Gaustad & Stein's 13F filing for Q1 2023, filed 17 Apr 2023.